← Leaderboards
Homayoon Farzadegan
Johns Hopkins University
$1,770,284
Attributed
$3,770,622
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2021–22$2M$1.5M$1M$500K$0
'21
'22
Funding mix
By agency
CDC$2,500,422 · 1
NIH$1,270,200 · 1
By mechanism
U01$2,500,422 · 1
R01$1,270,200 · 1
Top collaborators
- Margaret Daniele Fallin2 shared
- Christine Ladd-Acosta2 shared
- Rebecca Jean Landa2 shared
- Heather E Volk2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Gregory D Kirk$60,349,977
- David L Thomas$44,227,388
- Joseph B. Margolick$86,818,342
- Richard E Chaisson$50,014,616
- Norman J Haughey$28,823,277
Others in their field
Top investigators on “Antiaids Agent”
- Constance Ann Benson · University Of California, San Diego$85,157,000
- Willard Cates · Family Health International$66,963,584
- Stephen A Spector · University Of California, San Diego$62,271,387
- Fred M Gordin · Social And Scientific Systems, Inc.$50,695,408
- Robert Turner Schooley · University Of Colorado Denver$46,857,922
- Douglas D Richman · University Of California San Diego$18,822,170
Research focus
Antiaids AgentClinical ResearchDrug ResistanceGenotypeHiv InfectionsHuman Immunodeficiency Virus 1Human SubjectIntravenous Drug AbusePhenotypeSerology /SerodiagnosisSubstance Abuse Epidemiology
Grant awards (5)
Study to Explore Early Development (SEED) Follow up Studies, Components A, B, D & E$1,302,102
U01 · FY2022 · DD
Study to Explore Early Development (SEED) Follow up Studies, Components A, B, D & E$1,198,320
U01 · FY2021 · DD
EPIDEMIOLOGY OF DRUG RESISTANT HIV 1 IN IDUS$373,482
R01 · FY2002 · DA
EPIDEMIOLOGY OF DRUG RESISTANT HIV 1 IN IDUS$451,518
R01 · FY2001 · DA
EPIDEMIOLOGY OF DRUG RESISTANT HIV 1 IN IDUS$445,200
R01 · FY2000 · DA